• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. DENALI JUGULAR SYSTEM; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. DENALI JUGULAR SYSTEM; VENA CAVA FILTER Back to Search Results
Catalog Number DL900J
Device Problems Difficult to Remove (1528); Obstruction of Flow (2423)
Patient Problems Edema (1820); Pain (1994); Thrombosis (2100)
Event Date 08/28/2015
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: as the lot number for the device was not provided, a manufacturing review could not be performed.Investigation summary: the device was not returned for evaluation.Images and medical records were not provided for review.Therefore, the investigation is inconclusive for occlusion as no objective evidence has been provided to confirm any alleged deficiency with the filter.Based upon the available information, the definitive root cause is unknown.Labeling review: the current ifu (instructions for use) states: contraindications for use: the denali vena cava filter should not be retrieved if significant thrombus is in or near the filter.A review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(b)(6).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with trauma situation/motor vehicle accident.At some time post filter deployment, it was alleged that the patient allegedly experienced pain, leg swelling, and prominence of the veins on their abdomen.Furthermore, the patient allegedly had a doppler ultrasound that discovered that the patient had extensive dvt in the entire course of the bilateral lower extremity deep venous systems, with a mixture of occlusive and non-occlusive dvt in the right common femoral veins and right popliteal vein.There was an initial attempted but unsuccessful percutaneous removal procedure.The device was removed percutaneously.The current status of the patient is unknown.
 
Manufacturer Narrative
H10: manufacturing review: a device history record review could not be performed as the lot number is unknown.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately, ten months of post deployment, the patient underwent attempted filter retrieval, but the filter could not be removed due to chronic ilio-caval thrombosis at the level of the filter.The patient underwent ilio-caval revascularization for an embedded and chronically thrombosed filter.Around, four months later, the patient presented for filter retrieval, a 12-20 mm trilobed snare was then inserted through the right internal jugular sheath and used to engage the filter hook.Despite 6 lbs of tension, the filter could not be sheathed.A 12 french laser sheath was calibrated and advanced over the snare wire to the point of resistance.The laser sheath was activated to ablate through the scar tissue, and the filter was successfully removed using 3 pounds of tension.Therefore, the investigation is confirmed for retrieval difficulties.However, the investigation is inconclusive for occlusion of the inferior vena cava.Based upon the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.The current instructions for use states: contraindications for use: the denali vena cava filter should not be retrieved if significant thrombus is in or near the filter.H11:section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient in conjunction with trauma situation/motor vehicle accident.At some time post filter deployment, it was alleged that the patient allegedly experienced pain, leg swelling, and prominence of the veins on their abdomen.Furthermore, the patient allegedly had a doppler ultrasound that discovered that the patient had extensive dvt in the entire course of the bilateral lower extremity deep venous systems, with a mixture of occlusive and non-occlusive dvt in the right common femoral veins and right popliteal vein.There was an initial attempted but unsuccessful percutaneous removal procedure.The device was removed percutaneously.The current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DENALI JUGULAR SYSTEM
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key8065004
MDR Text Key126960559
Report Number2020394-2018-02009
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
PMA/PMN Number
K130366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Type of Report Initial,Followup
Report Date 12/06/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberDL900J
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/16/2018
Initial Date FDA Received11/13/2018
Supplement Dates Manufacturer Received11/26/2020
Supplement Dates FDA Received12/06/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
COUMADIN
Patient Outcome(s) Other;
Patient Age53 YR
-
-